Medexus Pharmaceuticals Inc. (TSX:MDP)
Canada · Delayed Price · Currency is CAD 5.30
+0.34 (6.85%)
Aug 11, 2026, 4:00 PM EST
Medexus Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Medexus Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $7.44. The average 1-year stock price forecast is 40.38% higher than the current stock price, while the lowest is $6.00 (+13.21%) and the highest is $9.00 (+69.81%).
Price Target: $7.44 (+40.38%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 29, 2026.
Analyst Ratings
The average analyst rating for Medexus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bloom Burton | Bloom Burton | Buy Maintains $6.00 | Buy | Maintains | $6.00 | +13.21% | Jun 29, 2026 |
Financial Forecast
Revenue This Year
113.65M
from 99.33M
Increased by 14.41%
Revenue Next Year
138.12M
from 113.65M
Increased by 21.53%
EPS This Year
0.38
EPS Next Year
0.66
from 0.38
Increased by 73.57%
EPS and Forward PE are based on non-GAAP adjusted numbers.